For the quarter ending 2025-06-30.
| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Unrealized (loss) gain on short-term investments (note 4) | -7,152 | |||
| Net loss for the period | -4,003,274 | |||
| Loss and comprehensive loss for the period | -4,010,426 | |||
| Basic EPS | -0.09 | |||
| Diluted EPS | -0.09 | |||
| Basic Average Shares | 44,388,550 | |||
| Diluted Average Shares | 44,388,550 | |||
ESSA Pharma Inc. (EPIX)
ESSA Pharma Inc. (EPIX)